AstraZeneca invests USD 3.5 billion in RnD, manufacturing in US Ruchika Sharma15 Nov 2024 3:08 PM ISTCambridge: AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company's research and...
Lubrizol, Polyhose sign MoU to manufacture medical tubing, expand capacity in Chennai Ruchika Sharma15 Nov 2024 1:04 PM ISTChennai: Lubrizol and Polyhose have signed a Memorandum of Understanding (MoU) to empower the Indian medical sector to achieve new levels of...
Granules India honoured with Golden Peacock Award for Sustainability Ruchika Sharma15 Nov 2024 11:00 AM ISTHyderabad: Granules India Limited, a pharmaceutical company, has announced that it has received the Golden Peacock Award for Sustainability....
Dr Reddy's Hit with Rs 27 Lakh Fine in Mexico Farhat Nasim14 Nov 2024 4:26 PM ISTNew Delhi: Hyderabad-based pharmaceutical giant, Dr Reddy’s Laboratories, has been fined approximately Rs 27 lakh by Mexico’s regulatory body,...
AstraZeneca, Daiichi Sankyo submits Datopotamab deruxtecan new BLA for accelerated approval in US for lung cancer Ruchika Sharma14 Nov 2024 3:15 PM ISTAstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan...
GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia Ruchika Sharma14 Nov 2024 1:15 PM ISTMississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or...
Ginkgo Bioworks advances collaboration with Merck to improve Biologics manufacturing Ruchika Sharma14 Nov 2024 12:33 PM ISTBoston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of...
Cipla gets 8 USFDA observations for Virgonagar facility Ruchika Sharma14 Nov 2024 12:01 PM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the Company's...
Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2 Ruchika Sharma13 Nov 2024 5:21 PM ISTNatco Pharma has announced an 83 percent on-year increase in its consolidated net profit for the September 2024 quarter, which rose to Rs 676 crore,...
Sanofi Gets CDSCO Panel Nod to Study Venglustat Dr. Divya Colin13 Nov 2024 5:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, the Subject Expert...
Shanghai Pharma Vice President expresses hope for increased investment from Indian pharma cos in China Ruchika Sharma13 Nov 2024 2:25 PM ISTShanghai: Li Dongming, Vice President of Shanghai Pharmaceuticals, expressed hope on Tuesday for more investment from Indian pharmaceutical...
USFDA accepts Shilpa Medicare CDMO partner Unicycive NDA for Oxylanthanum Carbonate Ruchika Sharma13 Nov 2024 12:13 PM ISTKarnataka: Shilpa Medicare CDMO partner Unicycive Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (USFDA) has...
